PGI toxic injection case: Victim dies during treatment

Chandigarh: The patient who was allegedly injected with a cocktail of toxic substances by a woman who managed to gain access into the gynaecology ward of PGI, died on Sunday. The 24-year-old patient, Harmeet Kaur was a resident of Rajpura, Patiala. She was admitted in PGI on November 7 in critical condition, after referral from another hospital.

The patient already had acute kidney injury, absent urine output and multi-organ dysfunction, which had resulted from delivery complications on November 4.

She had already received dialysis before referral to PGI.

On November 16, she was shifted to ICU as a consequence of the unknown substance injected into her through the accused, which aggravated her already critical condition. After the attempt on her life, she was put on life support with doctors closely monitoring her.

“Her condition kept worsening and despite best efforts by the treating team, she could not be resuscitated. The body will be handed over to the next of kin after completing medico-legal formalities by the police,” said PGI spokesperson Prof Vipin Koushal.

Last month, police caught the prime accused, Jaspreet Kaur who had administered the injection. During investigations, police found that the injection had been administered on the directions of the victim’s brother, Jasmeet Singh, who has been arrested along with the other accused.

The Asian Development Bank (ADB) has approved a $250 million loan to support the development of industrial corridors in India. The loan aligns with the National Industrial Corridor Development Program (NICDP) and aims to enhance the competitiveness of the manufacturing sector, generate high-quality jobs, and strengthen supply chains. The loan will be used for the development of multimodal logistics infrastructure and alternative financing solutions. The program also focuses on gender equality, workplace safety, and environmental practices. The ADB’s previous loan of $250 million contributed to the development of 11 industrial corridors.
Foreign medical graduates who returned to India due to the Covid pandemic or the Russia-Ukraine war must undergo compulsory one-year clinical clerkship to be eligible for CMRI. The National Medical Commission (NMC) clarified that medical colleges can charge up to Rs 5,000 per month for clinical clerkship. Students who completed their FMG course online after a break in the penultimate year must undergo two years of clinical clerkship. After successful completion, they can begin CMRI. The number of internship seats will be 7.5% of the permitted MBBS seats in old colleges and 100% in new medical colleges, according to the NMC.

Related Posts

ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection

OneSource Speciality Pharma announced that its partner Orbicular Pharmaceutical Technologies (Orbicular), together with its U.S.-based front-end partner (the ANDA holder), has secured tentative U.S. Food and Drug Administration (FDA) approval…

Ajanta Pharma gets USFDA Form 483 with five observations at Paithan plant

Ajanta Pharma said the United States Food and Drug Administration (USFDA) has completed an inspection at its Paithan manufacturing facility in Maharashtra, conducted between 13 April and 21 April 2026.…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection

ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection

Ajanta Pharma gets USFDA Form 483 with five observations at Paithan plant

Ajanta Pharma gets USFDA Form 483 with five observations at Paithan plant

Obesity drug market to gain as Indians pop the pill and Chinese bring more

Obesity drug market to gain as Indians pop the pill and Chinese bring more

Aurobindo Pharma Rs 800 Cr Buyback Opens Apr 23

Aurobindo Pharma Rs 800 Cr Buyback Opens Apr 23

Boehringer Ingelheim launches AI centre for pharma research in London

Boehringer Ingelheim launches AI centre for pharma research in London

Pharma exports rose 2% to over $31 billion in FY26 despite sharp decline in March

Pharma exports rose 2% to over $31 billion in FY26 despite sharp decline in March